3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
2
Recurrence
1
Disease Progression
1
Interventions
venetoclax
1
vandetanib
1
tremelimumab
1
ricolinostat
1
pomalidomide
1
pembrolizumab
1
pazopanib
1
niraparib
1
ibrutinib
1
enzastaurin
1
durvalumab
1
copanlisib
1
brigatinib
1
binimetinib
1
avasopasem manganese
1
abexinostat
1
Transplantation, Autologous
1
Steroids
1
Melphalan
1
Interleukin-2
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Dexamethasone
1
Blood Specimen Collection
1
Biopsy
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Disease Progression
×
Transplantation, Autologous
×
Clear all
NCT02043847
2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1
Completed
12 enrolled
12 charts